Evidence map›Paper›PMID 32002817›Full record

ArticleJournal of neurovirology2020

Cerebrospinal fluid pleocytosis as a predictive factor for CSF and plasma HIV RNA discordance and escape.

Sérgio Monteiro de Almeida, Indianara Rotta, Ana Paula de Pereira, Bin Tang, Anya Umlauf, Cléa Elisa Lopes Ribeiro, Scott Letendre, Ronald J Ellis, HIV Neurobehavioral Research Center (HNRC) Group

Open access · greenAbstract read
In one paragraph

Article in Journal of neurovirology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Cerebrospinal fluid CD14Journal of neurovirology · 2023
    Article
  6. CD3Journal of neuroimmunology · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Sérgio Monteiro de AlmeidaVirology Laboratory, Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brazil. sergio.ma@ufpr.br.ORCID 0000-0001-5690-105X
Indianara RottaVirology Laboratory, Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brazil.
Ana Paula de PereiraDepartment of Psychology, Universidade Federal do Paraná, Curitiba, PR, Brazil.
Bin TangDepartment of Medicine and Psychiatry, University of California, San Diego, CA, USA.
Anya UmlaufDepartment of Medicine and Psychiatry, University of California, San Diego, CA, USA.
Cléa Elisa Lopes RibeiroInfectious Diseases Unity, Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brazil.
Scott LetendreDepartment of Medicine and Psychiatry, University of California, San Diego, CA, USA.
Ronald J EllisDepartment of Neurosciences and Psychiatry, University of California, San Diego, CA, USA.
HIV Neurobehavioral Research Center (HNRC) Group
University of California San Diego · USHospital de Clínicas Universidade Federal do Paraná · BRUniversidade Federal do Paraná · BR

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello · 2001 to 2026
$50.4M
HIV Clade on Cognitive and Neurological Disorders BrazilR21MH076651 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLIS, RONALD J. · 2006 to 2007
$317k
NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214NIMH NIH HHS P30 MH062512NIMH NIH HHS R21 MH076651
6 · The paper itself

Abstract

The aims of this study were to investigate the frequency of HIV-1 RNA level discordance between the cerebrospinal fluid (CSF) and plasma and of CSF viral escape (CVE) in patients with HIV-1 subtype C on antiretroviral therapy, and evaluate the CSF white blood cell (WBC) performance characteristics in predicting CSF discordance in HIV+ group and the frequency of cognitive impairment in individuals with CSF HIV discordance or escape. HIV-1 RNA levels were assessed in plasma and CSF samples from 68 HIV+ participants without opportunistic infection. CSF discordance was found in 7.4% and CVE in 10%, with comparable frequencies between HIV-1B and C. Twenty samples (29%) showed increased CSF WBC counts. This group had higher CSF and plasma HIV-1 RNA levels than the group with normal WBC counts (p < 0.0001 and 0.006, respectively). The odds of CSF discordance were 18 times higher for a person with CSF WBC count of > 5 cells/mm

Indexed as

HIV InfectionsAdultAnti-HIV AgentsFemaleHIV-1HumansLeukocytosisMaleMiddle AgedRNA, ViralAnti-HIV AgentsRNA, ViralCentral nervous system (CNS)Cerebrospinal fluid (CSF)DiscordanceHIV-1ScapeWhite blood cell

Identifiers

PMID32002817
PMCPMC7261245
OpenAlexW3003211938

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.